Back | Next |
home / stock / ikt / ikt message board
Subject | By | Source | When |
---|---|---|---|
Do we have a winner?Turn around time? | CarlCarlMcB | investorshub | 04/07/2023 2:05:01 AM |
$IKT The gaining | conix | investorshub | 04/06/2023 11:17:24 PM |
$IKT The now last trade up | jedijazz | investorshub | 04/06/2023 9:34:16 PM |
$IKT Price gaining | conix | investorshub | 04/06/2023 6:54:28 PM |
$IKT news out | ProfitScout | investorshub | 04/06/2023 5:08:00 PM |
MomentumIts gaining | CarlCarlMcB | investorshub | 04/06/2023 3:15:05 PM |
The gaining last trade up | conix | investorshub | 04/06/2023 8:29:42 AM |
The now | conix | investorshub | 04/06/2023 7:29:46 AM |
$IKT Have a look at this | jedijazz | investorshub | 04/06/2023 4:21:36 AM |
$IKT bulls and bears | conix | investorshub | 04/06/2023 3:38:04 AM |
$IKT here we go bulls news is here | conix | investorshub | 04/05/2023 10:52:52 PM |
we got news | conix | investorshub | 04/05/2023 8:49:58 PM |
$IKT Do we have a winner?Turn around time? | conix | investorshub | 04/05/2023 4:47:42 PM |
$IKT Price now | kzivann | investorshub | 04/05/2023 3:13:40 PM |
The trading up | conix | investorshub | 04/05/2023 2:43:52 PM |
Price trading last trade up | conix | investorshub | 04/05/2023 1:19:12 PM |
Lets go go go go... Up up and away we go. | ProfitScout | investorshub | 04/05/2023 1:09:03 PM |
great article | conix | investorshub | 04/05/2023 12:32:10 PM |
$IKT The trading last trade up | conix | investorshub | 04/05/2023 11:59:02 AM |
what do you make of this data? | jedijazz | investorshub | 04/05/2023 11:31:19 AM |
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
Inhibikase Therapeutics Inc. Website:
BOSTON and ATLANTA, June 17, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinso...
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kin...
BOSTON and ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...